Skip to main content
. 2021 Dec 17;21(3):247–260. doi: 10.1080/15384101.2021.2015671

Figure 4.

Figure 4.

Silence of circGOT1 reversed cisplatin resistance to ESCC. (a-b). CCK-8 assay was used to measure the cell viability after knockdown of circGOT1 and treatment with increasing concentration of cisplatin (0, 2.5, 5, 10 µM). ©. The IC50 value of cisplatin was calculated after knockdown of circGOT1. ***P < 0.001.